Sie sind auf Seite 1von 2

Ranfac Marrow Cellution Bone Marrow Aspiration System Outperforms

EMCYTE BMC System in Comparative Analysis

In a 3 patient study, bone marrow collected by the Marrow Cellution aspiration system had
significantly more CD 34+ and CFU-f per mL as compared to the EMCYTE BMC system without
requiring additional manipulation via centrifugation.

Steubenville, OH, July 12, 2017 --(PR.com)-- According to the white paper titled, Comparative
Analysis of Marrow Cellutions and EMCYTE Bone Marrow Concentrate Systsem (June 2017), three
sets of bone marrow aspirate samples were collected using the EMCYTE Bone Marrow Concentrate
(BMC) system and the Marrow Cellution Bone Marrow Aspirate (BMA) System and prepared via each
manufacturers' instructions. The procedures were performed by Michael Scarpone, D.O., Medical
Director of Trinity Sports Medicine, Steubinville, OH. Samples were analyzed for TNC count, CD 34+
count and CFU-f by Daniel Kuebler, Ph.D. at Franciscan University, Steubenville, OH.

The Marrow Cellution aspiration system had significantly more CD 34+ and CFU-f per mL as
compared to the EMCYTE BMC system with less contaminating peripheral blood as indicated by the
higher ratio of CFU-f to nucleated cells. Additionally, since the Marrow Cellution system does not
require centrifugation, it required less preparation time, lower volume of aspirate, and did not require
additional manipulative steps outside the sterile field compared to the EMCYTE BMC System.

The White Paper with complete details of the analysis may be found by clicking here.

The patent pending Marrow Cellution Bone Marrow Aspirate System (manufactured by Ranfac Corp.,
Avon, MA) claims to be able to harvest high concentrations of key stem and progenitor cells from bone
marrow aspirate without the need for further processing via centrifugation by using its proprietary
technology to limit peripheral blood dilution during the aspiration process. More information may be
found at www.marrowcellution.com.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Ranfac Corp.
Harlan Adler
508 588 4400 ext. 130
Contact via Email
marrowcellution.com

Online Version of Press Release:


You can read the online version of this press release at: http://www.pr.com/press-release/723037

Page 2/2
PR.com Press Release Distribution Terms of Use